Survival with chronic myelogenous leukemia: the outcome of a patient who had one of the longest survivals

Oncology. 1998 Nov-Dec;55(6):607. doi: 10.1159/000011920.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use
  • Humans
  • Hydroxyurea / therapeutic use
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
  • Male
  • Survivors*
  • Time Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Hydroxyurea